siponimod

CHEBI:CHEBI_747930

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
siponimod
rxcui
2594797
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
route
ORAL
dosage_form
TABLET, FILM COATED
active_ingredient_strength
.25 mg/1
pharm_class_moa
Sphingosine 1-Phosphate Receptor Modulators [MoA]
pharm_class
Sphingosine 1-phosphate Receptor Modulator [EPC]
pharm_class_epc
Sphingosine 1-phosphate Receptor Modulator [EPC]
marketing_start_date
20190326
package_marketing_start_date
01-MAR-22
labeler_name
Novartis Pharma Stein AG
manufacturer_name
Novartis Pharmaceuticals Corporation
brand_name
MAYZENT
brand_name_base
MAYZENT
product_ndc
0078-0979
application_number
NDA209884
spl_id
0d455e65-f44e-455d-b9b6-02e7fc259f0b
active_ingredient_name
SIPONIMOD
package_ndc
0078-0979-92
package_description
28 TABLET, FILM COATED in 1 BOTTLE (0078-0979-92)
unii
RR6P8L282I
spl_set_id
44492772-5aed-4627-bd85-e8e89f308bb3
nui
N0000181815
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class